98%
921
2 minutes
20
For a target task where the labeled data are unavailable, domain adaptation can transfer a learner from a different source domain. Previous deep domain adaptation methods mainly learn a global domain shift, i.e., align the global source and target distributions without considering the relationships between two subdomains within the same category of different domains, leading to unsatisfying transfer learning performance without capturing the fine-grained information. Recently, more and more researchers pay attention to subdomain adaptation that focuses on accurately aligning the distributions of the relevant subdomains. However, most of them are adversarial methods that contain several loss functions and converge slowly. Based on this, we present a deep subdomain adaptation network (DSAN) that learns a transfer network by aligning the relevant subdomain distributions of domain-specific layer activations across different domains based on a local maximum mean discrepancy (LMMD). Our DSAN is very simple but effective, which does not need adversarial training and converges fast. The adaptation can be achieved easily with most feedforward network models by extending them with LMMD loss, which can be trained efficiently via backpropagation. Experiments demonstrate that DSAN can achieve remarkable results on both object recognition tasks and digit classification tasks. Our code will be available at https://github.com/easezyc/deep-transfer-learning.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/TNNLS.2020.2988928 | DOI Listing |
Int J Disaster Risk Reduct
February 2025
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
With increasingly severe weather events compounded with additional disasters, environmental shocks and stressors, and socio-economic challenges, there is a growing sense of urgency to build resilience, resulting in the need for assessment tools. We conducted a review of empirical studies that measured household and community resilience to environmental shocks and stressors among urban populations in low- and middle-income countries. This review was conducted to 1) understand how empirical studies measure resilience, 2) identify gaps in current practices, and 3) provide theory-informed recommendations to bridge gaps.
View Article and Find Full Text PDFNeural Netw
August 2025
School of Electrical and Information Engineering, Tianjin University, 300072, Tianjin, China. Electronic address:
Major Depressive Disorder (MDD) is a common mental illness that seriously jeopardizes the physical and mental health of patients. Accurate detection of MDD is crucial for treatment. Currently, there are significant differences in the EEG signals of each MDD patient, leading to lower accuracy of cross-subject MDD detection.
View Article and Find Full Text PDFAm J Intellect Dev Disabil
September 2025
Siddharth Srivastava and Kristina Johnson, Department of Neurology, Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School; Cristan Farmer, Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Instit
Phelan-McDermid syndrome (PMS), caused by SHANK3 haploinsufficiency, lacks natural history data. We report the trajectory of adaptive behavior from a prospective, longitudinal, natural history study. English-speaking people aged 3-21 years with a PMS molecular diagnosis were followed over 2 years.
View Article and Find Full Text PDFJ Psychiatr Res
August 2025
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Electronic address:
Background: Ketamine is effective for treatment-resistant depression (TRD), where its mechanism remains unclear. Though the amygdala plays an important role in emotional processing and mood state, no study has explored the relationship between amygdalar subfield volumes and ketamine's effect in patients with TRD. We hypothesized that amygdalar subfield volume changes would correlate with clinical response to ketamine in patients with TRD.
View Article and Find Full Text PDFACS Med Chem Lett
August 2025
Faculty of Pharmaceutical Sciences, Sojo University, 4-22-1, Ikeda, Nishi-ku, Kumamoto 860-0082, Japan.
Nateglinide is a short-acting insulin secretagogue clinically used for the treatment of type 2 diabetes mellitus. Nateglinide exhibits a high plasma protein binding rate of approximately 98%, primarily binding to subdomain IIIA of human serum albumin (HSA). Here, we determined the crystal structure of the HSA-nateglinide complex at 2.
View Article and Find Full Text PDF